Full year 2025 financial guidance excludes any potential share repurchase or additional M&A activity. CEO Dr. Steve Cutler commented, "ICON continues to navigate dynamic clinical development ...
SO WHAT: If you purchased EA securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a ...
ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.
The State Council for Educational Research and Training (SCERT) director Rahul Rekhawar has given instructions to observe a business guidance week for students of classes 9 to 12 in the state.
The revised target comes in response to ICON's 2025 guidance, which Windley noted as being softer than expected. According to InvestingPro data, ICON's stock has experienced a significant 8.71% ...
Tuesday, TD Cowen reaffirmed its Buy rating and $285.00 price target on ICON plc shares (NASDAQ:ICLR), following the company's financial guidance. According to InvestingPro analysis, ICON ...